Brooks Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

24.70

24.70

24.70

24.70

16.19

Share application money

-

-

-

-

5.55

Preference share capital

-

-

-

-

-

Reserves & surplus

32.08

40.30

39.51

73.71

83.41

Loan funds

Secured loans

5.66

4.92

8.16

24.01

28.33

Unsecured loans

-

-

-

-

-

Total

62.44

69.93

72.37

122.43

133.48

Uses of funds

Fixed assets

Gross block

21.82

20.66

19.70

132.46

132.41

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

6.81

5.53

4.74

19.43

14.52

Net block

15.01

15.14

14.96

113.02

117.89

Capital work-in-progress

-

1.12

0.02

0.11

0.29

Investments

46.85

46.84

46.81

0.02

0.02

Net current assets

Current assets, loans & advances

30.56

40.35

31.21

44.71

49.76

Less : current liabilities & provisions

29.98

33.53

20.62

35.44

34.47

Total net current assets

0.58

6.82

10.59

9.27

15.29

Miscellaneous expenses not written

-

-

-

-

-

Total

62.44

69.93

72.37

122.43

133.48

Notes:

Book value of unquoted investments

46.85

46.84

46.81

0.02

0.02

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

20.84

24.79

29.70

25.77

25.90

Number of equity sharesoutstanding (Lacs)

247.03

247.03

247.03

247.03

161.86